Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Researchers find possible biological reason why people with diabetes are prone to depression

Researchers find possible biological reason why people with diabetes are prone to depression

Women who develop gestational diabetes perform worse on cognitive function tests

Women who develop gestational diabetes perform worse on cognitive function tests

Empagliflozin lowers blood pressure in patients with Type 2 diabetes and hypertension

Empagliflozin lowers blood pressure in patients with Type 2 diabetes and hypertension

Treatment with diabetes drug liraglutide improves cardiovascular risk factors

Treatment with diabetes drug liraglutide improves cardiovascular risk factors

Researchers shown how free radicals contribute to fatty liver disease

Researchers shown how free radicals contribute to fatty liver disease

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

Greenlander study identifies single mutation with large diabetes risk

Greenlander study identifies single mutation with large diabetes risk

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

New research reveals gene's role in type 1 diabetes

New research reveals gene's role in type 1 diabetes

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

Detective work maps special gene variant among Greenlanders which plays role in type 2 diabetes

Detective work maps special gene variant among Greenlanders which plays role in type 2 diabetes

Mayo Clinic study: Reversing current thought on treatment of cirrhotic patients with type 2 diabetes

Mayo Clinic study: Reversing current thought on treatment of cirrhotic patients with type 2 diabetes

U of MD researchers to use $3.7 million NIH grant to develop novel method to treat monogenic diabetes

U of MD researchers to use $3.7 million NIH grant to develop novel method to treat monogenic diabetes

Joslin and CSHI partner to develop online "virtual" case based interactive educational materials

Joslin and CSHI partner to develop online "virtual" case based interactive educational materials

Animas' predictive algorithm technology maintains glucose above hypoglycemic levels

Animas' predictive algorithm technology maintains glucose above hypoglycemic levels

AADE recommends easy-to-follow tips for diabetes management

AADE recommends easy-to-follow tips for diabetes management

New studies shed light on the mechanism of childhood obesity

New studies shed light on the mechanism of childhood obesity

Researchers identify muscle-building mechanism that could be important in addressing sarcopenia

Researchers identify muscle-building mechanism that could be important in addressing sarcopenia

BIPI, Lilly announce resubmission of empagliflozin NDA to FDA for treatment of type 2 diabetes

BIPI, Lilly announce resubmission of empagliflozin NDA to FDA for treatment of type 2 diabetes

No link between consumption of cow's milk-based formula and development of autoantibodies in kids

No link between consumption of cow's milk-based formula and development of autoantibodies in kids

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.